Low adherence and underuse of lipid-lowering therapy increased atherosclerotic cardiovascular disease risk in a large, diverse US cohort.
The post Real-World Gaps in Lipid Therapy for ASCVD Risk first appeared on Physician’s Weekly.
Real-World Gaps in Lipid Therapy for ASCVD Risk
Leave a Reply
We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc. Check our landing page for details.